Literature DB >> 2726418

A ready-to-use activated charcoal mixture. Adsorption studies in vitro and in dogs: its influence on the intestinal secretion of theophylline in a rat model.

C M Rademaker1, A van Dijk, M H de Vries, F Kadir, J H Glerum.   

Abstract

A practical, ready-to-use preparation of activated charcoal (AZU mixture) for application in toxicology has been formulated. To establish its efficacy, the formulation was tested in vitro and in dogs. The in vitro adsorption capacity was compared to that of freshly prepared charcoal suspension in water (CW) and to Carbomix. Langmuir adsorption coefficients demonstrated small but clinically insignificant differences in adsorption capacity between the preparations. The laxative sodium sulfate did not reduce the adsorption capacity of charcoal in vitro. Dogs were given 60 mg of paracetamol per kg as an oral solution followed by 5 g of activated charcoal preparation. The area under the plasma concentration versus time curve (control 2955 +/- 353 mg.min-1.l-1) was significantly reduced following CW (921 +/- 453) and AZU (786 +/- 270). The premixed AZU charcoal formulation is efficacious, inexpensive and overcomes the problems of bed-side preparation. An isolated vascularly perfused rat small intestine can be used to describe the effect of activated charcoal on the intestinal secretion of theophylline.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2726418     DOI: 10.1007/bf01962976

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  18 in total

1.  Inhibition by ice cream of the antidotal efficacy of activated charcoal.

Authors:  G Levy; D M Soda; T A Lampman
Journal:  Am J Hosp Pharm       Date:  1975-03

2.  THE BLACK BOTTLE. A CONSIDERATION OF THE ROLE OF CHARCOAL IN THE TREATMENT OF POISONING IN CHILDREN.

Authors:  L E HOLT; P H HOLZ
Journal:  J Pediatr       Date:  1963-08       Impact factor: 4.406

3.  Adsorption of drugs and poisons by activated charcoal.

Authors:  W J Decker; H F Combs; D G Corby
Journal:  Toxicol Appl Pharmacol       Date:  1968-11       Impact factor: 4.219

4.  Enhancement of theophylline clearance by oral activated charcoal.

Authors:  W G Berlinger; R Spector; M J Goldberg; G F Johnson; C K Quee; M J Berg
Journal:  Clin Pharmacol Ther       Date:  1983-03       Impact factor: 6.875

5.  Isolated perfusion of the small intestine using perfluorotributylamine as artificial oxygen carrier.

Authors:  F Hartmann; D Vieillard-Baron; R Heinrich
Journal:  Adv Exp Med Biol       Date:  1984       Impact factor: 2.622

6.  Characteristics of statistical parameters used to interpret least-squares results.

Authors:  R B Davis; J E Thompson; H L Pardue
Journal:  Clin Chem       Date:  1978-04       Impact factor: 8.327

7.  Evaluation of five activated charcoal formulations for inhibition of aspirin absorption and palatability in man.

Authors:  E C Scholtz; J M Jaffe; J L Colaizzi
Journal:  Am J Hosp Pharm       Date:  1978-11

8.  Palatability of sucrose-, sorbitol-, and saccharin-sweetened activated charcoal formulations.

Authors:  D O Cooney
Journal:  Am J Hosp Pharm       Date:  1980-02

9.  Antidotal efficacy of activated charcoal in presence of jam, starch and milk.

Authors:  R De Neve
Journal:  Am J Hosp Pharm       Date:  1976-09

10.  In-vivo comparison of the adsorption capacity of "superactive charcoal" and fructose with activated charcoal and fructose.

Authors:  D C Chung; J E Murphy; T W Taylor
Journal:  J Toxicol Clin Toxicol       Date:  1982-04
View more
  2 in total

1.  Amitriptyline, clomipramine, and doxepin adsorption onto sodium polystyrene sulfonate.

Authors:  Akram Jamshidzadeh; Fatemeh Vahedi; Omid Farshad; Hassan Seradj; Asma Najibi; Gholamreza Dehghanzadeh
Journal:  Daru       Date:  2014-01-22       Impact factor: 3.117

2.  Comparison of activated charcoal and sodium polystyrene sulfonate resin efficiency on reduction of amitriptyline oral absorption in rat as treatments for overdose and toxicities.

Authors:  Gholamhossein Yousefi; Mohammad Bizhani; Akram Jamshidzadeh; Saeid Gholamzadeh
Journal:  Iran J Basic Med Sci       Date:  2017-01       Impact factor: 2.699

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.